---
figid: PMC3094802__nihms290166f3
figtitle: Diagram of putative therapeutic target in the Notch pathway
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC3094802
filename: nihms290166f3.jpg
figlink: /pmc/articles/PMC3094802/figure/F3/
number: F3
caption: Diagram of putative therapeutic target in the Notch pathway. Notch signaling
  could be inhibited theoretically at many different levels. It is possible to (1)
  interfere with Notch-ligand interactions, (2) inhibit receptor activation, (3) promote
  Notch ubiquitination and degradation, (4) inhibit its translocation to the nuclear
  compartment and (5) inhibit NICD nuclear complex formation.
papertitle: 'Notch Signaling Proteins: Legitimate Targets for Cancer Therapy.'
reftext: Zhiwei Wang, et al. Curr Protein Pept Sci. ;11(6):398-408.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9567398
figid_alias: PMC3094802__F3
figtype: Figure
redirect_from: /figures/PMC3094802__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3094802__nihms290166f3.html
  '@type': Dataset
  description: Diagram of putative therapeutic target in the Notch pathway. Notch
    signaling could be inhibited theoretically at many different levels. It is possible
    to (1) interfere with Notch-ligand interactions, (2) inhibit receptor activation,
    (3) promote Notch ubiquitination and degradation, (4) inhibit its translocation
    to the nuclear compartment and (5) inhibit NICD nuclear complex formation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Jag
  - ord
  - Dl
  - .na.character
  - Tapdelta
  - deltaTry
  - osa
  - nej
  - Su(H)
  - 'On'
  - PSMB6
  - YY1
  - DLL1
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - EP300
  - CSHL1
  - RBPJ
  - SMPX
---
